Molina to drop Medicare Advantage prescription drug plans in 2027 

(By: Jakob Emerson for Becker’s Hospital Review)

Molina Healthcare will exit the Medicare Advantage Part D business in 2027, the company announced alongside its fourth quarter and full year 2025 earnings report published Feb. 5.

The MAPD product represents approximately $1 billion in annual premiums. Molina said the product does not align with its strategic shift to focus exclusively on its $5 billion dual eligible business, and that underperformance in MAPD is costing it an estimated $1.00 per diluted share in 2026. Continue reading here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.